Emerging paradigms in redox regulation: the role of selenoproteins in normal and malignant hematopoiesis
Experimental Hematology · 2026
DOI: 10.1016/j.exphem.2025.105346 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Experimental Hematology, 2026. Verfasst von Yumi Aoyama und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology-Oncology, Institute of Biomedical Research and Innovation, Foundation for Biomedical Research and Innovation at Kobe, Kobe, …. Hauptthemen laut MEDLINE: Selenoproteins, Hematopoiesis, Hematopoietic Stem Cells, Hematologic Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 132 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kobayashi Foundation for Cancer Research, Mitsubishi Foundation, Japanese Society of Hematology.
Abstract (Originalsprache)
Selenoproteins-a unique class of antioxidant enzymes characterized by the incorporation of selenocysteine at their catalytic core-function as pivotal regulators of redox homeostasis in hematopoiesis. This review elucidates how selenoprotein-mediated redox control orchestrates hematopoietic stem cell (HSC) fate decisions, maintaining the critical balance between self-renewal and differentiation. The glutathione peroxidase (GPX) family, particularly GPX1 and GPX4, plays indispensable roles in hydrogen peroxide detoxification and protection against lipid peroxidation-induced ferroptotic cell death, respectively. Similarly, thioredoxin reductases (TXNRDs) sustain critical redox equilibrium via thioredoxin regeneration. Recent studies demonstrate that these redox regulators facilitate the proliferation and differentiation of HSCs and mature lineages. Selenoprotein deficiency disrupts HSC fitness, impairs B- and erythroid-lineage maturation, and induces B-to-myeloid lineage switching-pathogenic features observed in aged hematopoiesis, highlighting the critical roles of selenoproteins in balanced, healthy hematopoiesis. Emerging evidence demonstrates that leukemic cells also exploit selenoprotein pathways to mitigate oxidative stress, suggesting that selective modulation of specific selenoproteins may constitute a promising therapeutic approach, provided we delineate their differential utilization between normal and malignant hematopoiesis. Selenoproteins function at the intersection of several transcriptional networks, including NRF2, whose orchestrated antioxidant responses may alter during aging and malignant transformation. Indeed, selenoproteins possess unique properties and function with tissue-specific expression patterns and nonredundant or redundant functions across different hematopoietic lineages. Understanding the contribution of selenoproteins to hematopoietic regulation offers promising avenues for developing targeted therapeutic strategies in hematologic disorders and rejuvenating aged hematopoiesis, potentially through precision-guided modulation of selenoprotein-dependent pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Hematology-Oncology, Institute of Biomedical Research and Innovation, Foundation for Biomedical Research and Innovation at Kobe, Kobe, Japan; Department of Hematology, Graduate School of Medicine, Kyoto Un…
- Department of Hematology-Oncology, Institute of Biomedical Research and Innovation, Foundation for Biomedical Research and Innovation at Kobe, Kobe, Japan; Department of Cancer Pathology, Graduate School of Medicine and…
Förderung
- Kobayashi Foundation for Cancer Research
- Mitsubishi Foundation
- Japanese Society of Hematology
- Uehara Memorial Foundation
- Core Research for Evolutional Science and Technology
- Cell Science Research Foundation
- Japan Science and Technology Agency
- American Society of Hematology
Zitieren
APA
Aoyama, Y., Yamazaki, H., & Inoue, D. (2026). Emerging paradigms in redox regulation: the role of selenoproteins in normal and malignant hematopoiesis. Experimental Hematology. https://doi.org/10.1016/j.exphem.2025.105346
Vancouver
Aoyama Y, Yamazaki H, Inoue D. Emerging paradigms in redox regulation: the role of selenoproteins in normal and malignant hematopoiesis. Experimental Hematology. 2026. doi:10.1016/j.exphem.2025.105346
BibTeX
@article{Aoyama2026,
author = {Aoyama, Yumi and Yamazaki, Hiromi and Inoue, Daichi},
title = {Emerging paradigms in redox regulation: the role of selenoproteins in normal and malignant hematopoiesis},
journal = {Experimental Hematology},
year = {2026},
doi = {10.1016/j.exphem.2025.105346}
}
EUVIMED